Activity of Antitumor Drugs Against African Trypanosomes
Open Access
- 1 February 1979
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 15 (2) , 157-160
- https://doi.org/10.1128/aac.15.2.157
Abstract
Of 49 compounds known to have antitumor properties, 6 were found to have significant activity against Trypanosoma rhodesiense infections in mice. Activity against the African trypanosomes has not been reported previously for any of these six compounds. In order of decreasing activity these compounds were: (i) imidazole-4-carboxamide, 5-(3,3-dimethyl-1,1-triazene), (ii) inosine diglycolaldehyde, (iii) cis -diamminedichloro-platinum, (iv) streptozotocin, (v) coralyne sulfate, and (vi) 5-fluoro-2′-deoxyuridine. The percentage of “hits” (12.2%) from these known antitumor agents was approximately twice as great as when other means are employed for the selection of compounds for this test system.This publication has 6 references indexed in Scilit:
- Metabolism and chemotherapy of African trypanosomes.1977
- Screening Large Numbers of Compounds in a Model Based on Mortality of Trypanosoma Rhodesiense Infected Mice *The American Journal of Tropical Medicine and Hygiene, 1976
- Trypanocidal activity of antitumour antibodies and other metabolic inhibitors.1975
- Carbohydrate metabolism in cancer cells and the molecular correlation conceptThe Science of Nature, 1968
- Sensitivity of trypanosoma equiperdum to the action of tumor-inhibitory antibiotics in vitroBiochemical Pharmacology, 1965
- Inhibition of Ascites Tumour Growth by the Trypanocide, Ethidium Bromide, in Combination with AzaserineNature, 1962